batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Dethroning Opdivo in bladder cancer falls to Niagara 25 June 2024 ISTH 2024 – Takeda's marker for Genmab and Sanofi 24 June 2024 Syncona goes deeper into oncology 20 June 2024 iTeos’s TIGIT goes pivotal at last 19 June 2024 Day One goes where Pfizer and AbbVie feared to tread 19 June 2024 No Truqap déjà vu in triple-negative breast cancer 18 June 2024 Piccolo points the way to earlier Elahere use 7 June 2024 The markets bet on a Geron buyout 7 June 2024 Load More